CENOBAMATE
| Brand name | XCOPRI |
|---|---|
| Active ingredient | CENOBAMATE |
| Strength | 150MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | March 2020 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 11654133 | June 2039 | use U-3610 |
| 7598279 | October 2032 | substance |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.